Constrictive bronchiolitis obliterans is an important respiratory illness because of its underlying irreversible fibrotic process, and is defined as concentric fibrosis in the bronchiolar ...
RS BioTherapeutics, whose mission is to develop life-changing medicines for the millions of people suffering from deadly lung diseases characterized by pulmonary inflammation, is pleased to announce ...
Relation has announced two strategic collaborations with GSK, focusing on the discovery and validation of therapeutics that target fibrotic diseases and osteoarthritis. Relation will obtain a $45m ...
Session: Poster and Exhibition Hall Reception Poster Title:PALI-2108, a Colon-Specific PDE4B Inhibitor Prodrug is Activated in the Colon and Reduces Ulcerative Colitis Symptoms in an Acute Colitis DSS ...
In an exciting advancement for dermatological science, researchers have uncovered the pivotal role of vitamin D and the enzyme CYP24A1 in the development of keloid scars—an elusive and challenging ...
Evotec SE, together with Yonsei University and the Korean biotech company Zymedi, will receive a $4.5 million grant from the ...
Prolonged hypoxia and tissue damage from surgery play key roles in adhesion formation, at least in part by inducing the release of known fibrotic mediators such as HIF1a, TGF-β1, TGF-β2 ...
Researchers from Hokkaido University of Science presented data from a study that aimed to assess the impact of reverse erythroblastosis virus (REV)-ERBα agonist, SR-9009, on renal fibrosis.
Hong Kong-based Insilico Medicine has begun a Phase 1 trial of its AI-discovered and AI-designed anti-fibrotic small molecule inhibitor. Currently referred to as ISM001-055, the drug is meant to ...
For the purely fibrotic lesion, the corticosteroid should be stopped shortly after stabilization as adverse reactions and possible interference with the natural healing process outweigh the benefit.